Content area
Full text
When Sanofi ($SNY) began work on its mobile iBGStar glucose monitor three years ago, Apple's ($APPL) iPhone was the dominant smartphone on the market. And last year the French drug giant released the glucose monitor only for iPhone and iPod Touch devices, PMLive reported. Yet Sanofi is reassessing its platform strategy for the iBGStar product after several years of rapid change in the smartphone market.
"We need to be more device agnostic, so our monitors can work on more platforms and offer more functionality," Jason Lovatt, Sanofi U.K.'s brand lead for blood glucose monitoring, told...